已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Impact of Conditioning Regimen and Graft-versus-Host Disease Prophylaxis on The Outcome of Haploidentical Peripheral Blood Stem Cell Transplantation for High-Risk Severe Aplastic Anemia in Children and Young Adults: A Report from the Pediatric Severe Aplastic Anemia Consortium of India

医学 内科学 氟达拉滨 移植 再生障碍性贫血 噻替帕 移植物抗宿主病 梅尔法兰 环磷酰胺 造血干细胞移植 布苏尔班 全身照射 养生 胃肠病学 外科 骨髓 化疗
作者
Gaurav Kharya,Sarita Rani Jaiswal,Sunil Bhat,Revathi Raj,Satya Prakash Yadav,Vikas Dua,Santanu Sen,Atish Bakane,Shobha Badiger,Ramya Uppuluri,Neha Rastogi,Mansi Sachdev,Bharti Sharma,Ashraf Saifullah,Suparno Chakrabarti
出处
期刊: [Elsevier BV]
卷期号:29 (3): 199.e1-199.e10 被引量:12
标识
DOI:10.1016/j.jtct.2022.12.010
摘要

Allogenic hematopoietic cell transplantation (HCT) is the best curative approach for patients with severe aplastic anemia (SAA). The outcomes of HCT from haploidentical family donors (HFDs) have improved, making it a feasible option for patients lacking an HLA-identical donor. However, data on HFD-HCT for younger patients with SAA is sparse. In this multicenter retrospective study, we evaluated the outcomes of 79 patients undergoing HFD-HCT for SAA. All the patients were heavily pretransfused, the median time to HCT was >12 months, and 67% had failed previous therapies. Conditioning was based on fludarabine (Flu)-cyclophosphamide (Cy)-antithymocyte globulin (ATG)/total body irradiation (TBI) with or without thiotepa/melphalan (TT/Mel). Post-transplantation Cy (PTCy) and calcineurin inhibitors (CNIs)/sirolimus were used as graft-versus-host disease (GVHD) prophylaxis with or without abatacept. The rate of primary graft failure (PGF) was 16.43% overall, lower in patients conditioned with TT/Mel. The incidences of acute and chronic GVHD were 26.4% and 18.9%, respectively. At a median follow-up of 48 months, the overall survival (OS) and event-free survival (EFS) were 61.6% and 58.1%, respectively. Both OS and EFS were better in the TT/Mel recipients and with abatacept as GVHD prophylaxis. On multivariate analysis, the use of abatacept was found to favorably impact the outcome variables, including GVHD and EFS. Our study suggests that PTCy-based HFD-HCT is a reasonable option for young patients with high-risk SAA, in whom optimization of conditioning and GVHD prophylaxis might further improve outcomes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
哈哈发布了新的文献求助10
1秒前
jiangchenyu关注了科研通微信公众号
2秒前
Miracle_wh完成签到 ,获得积分10
3秒前
天天快乐的应助被刘刘采纳,获得30
6秒前
6秒前
地西他滨发布了新的文献求助10
7秒前
疏水无纺布完成签到,获得积分10
7秒前
jing32yi完成签到,获得积分10
7秒前
青年才俊发布了新的文献求助10
7秒前
长情靖雁完成签到,获得积分10
8秒前
8秒前
LOVE17发布了新的文献求助10
10秒前
11秒前
布里田完成签到 ,获得积分10
11秒前
Hello的应助被Victoria采纳,获得10
12秒前
12秒前
王王碎冰冰完成签到,获得积分10
13秒前
小二郎的应助被Tsuki采纳,获得10
13秒前
13秒前
失眠念柏完成签到 ,获得积分10
14秒前
歪特发布了新的文献求助10
14秒前
Brave发布了新的文献求助80
15秒前
16秒前
17秒前
甜蜜元绿完成签到,获得积分10
18秒前
ke发布了新的文献求助10
18秒前
袁123发布了新的文献求助10
19秒前
LSH发布了新的文献求助10
19秒前
20秒前
CipherSage的应助被yy睡不醒采纳,获得30
21秒前
21秒前
尊嘟假嘟的应助被TaraMorgan125采纳,获得40
22秒前
stoneco完成签到,获得积分20
22秒前
23秒前
小手冰凉完成签到 ,获得积分10
23秒前
传奇3的应助被horse82采纳,获得10
23秒前
仁爱的梦曼完成签到,获得积分10
23秒前
Shirong_Peng发布了新的文献求助10
23秒前
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194470
求助须知:如何正确求助?哪些是违规求助? 9580227
关于积分的说明 21870293
捐赠科研通 7794034
什么是DOI,文献DOI怎么找? 3437667
关于科研通互助平台的介绍 2560986
邀请新用户注册赠送积分活动 2484393